Gujarat Fluorochemicals
- Market Cap
- ₹54,186 Cr
- P/E
- 80.98
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 9.64%
- Debt to Equity
- 0.28
- EPS (TTM)
- ₹60.91
- Book Value
- ₹763.95
- Market Cap
- ₹54,186 Cr
- P/E (TTM)
- 80.98
- P/B
- 6.46
- ROE
- 7.82%
- Dividend Yield
- 0.06%
- EBITDA
- ₹1,332 Cr
- 52W High
- ₹5,018.90
- 52W Low
- ₹2,916.60
- Day Range
- ₹4,877.00 – ₹5,018.90
- Volume
- 1,09,946
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| Median 7 companies | 1,620.30 | 56.75 | 21,506 | 6.46 | 0.20% | 9.82% | 11.90% | 5,853 | 661 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 51
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 22
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 78
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 56
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 94
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 52
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
4- Stock is trading at 6.46 times its book value
- Company has a low return on equity of 7.94% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 6.44% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 5 | 12 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 64.00
- Neutral
- MACD (12,26,9)
- 119.28
- Bullish
- SMA (50)
- 4,538.12
- Bullish
- SMA (200)
- 3,981.03
- Bullish
As of
Analyst Rating
10 of 14 analysts rate Buy, 2 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +13.52% |
|---|---|
| 3Y | −4.22% |
| 1Y | +5.47% |
| TTM | +20.33% |
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | −24.30% |
| 1Y | +5.13% |
| TTM | −2.51% |
Operating cash flow
| 5Y | +9.30% |
|---|---|
| 3Y | +9.15% |
| 1Y | +76.33% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +1.47 pp |
|---|---|
| 3Y | −10.52 pp |
| 1Y | +0.82 pp |
| TTM | −1.59 pp |
Revenue by year
| Mar 2018 | ₹3,851 Cr |
|---|---|
| Mar 2019 | ₹2,729 Cr |
| Mar 2020 | ₹2,606 Cr |
| Mar 2021 | ₹2,650 Cr |
| Mar 2022 | ₹3,954 Cr |
| Mar 2023 | ₹5,685 Cr |
| Mar 2024 | ₹4,281 Cr |
| Mar 2025 | ₹4,737 Cr |
| Mar 2026 | ₹4,996 Cr |
Net profit by year
| Mar 2018 | ₹240 Cr |
|---|---|
| Mar 2019 | ₹1,246 Cr |
| Mar 2020 | ₹189 Cr |
| Mar 2021 | −₹222 Cr |
| Mar 2022 | ₹776 Cr |
| Mar 2023 | ₹1,323 Cr |
| Mar 2024 | ₹435 Cr |
| Mar 2025 | ₹546 Cr |
| Mar 2026 | ₹574 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Gujarat Fluorochemicals Ltd trades at ₹4,978.6 as of 2026-11-19 with a market cap of ₹54,689.92 crore and a P/E (TTM) of 81.74x. The company has delivered a 20% TTM sales growth but profitability remains under pressure with ROE at 7.25% and a 3-year compounded profit decline of -24%.
- TTM revenue growth of 20% signals a meaningful acceleration in top-line momentum after a 3-year compounded sales decline of -4%
- Stock has delivered a 1-year CAGR of 37%, significantly outperforming broader markets and reflecting renewed investor confidence
- Debt-to-equity ratio stands at a manageable 0.35, indicating a relatively conservative balance sheet
- 5-year compounded sales growth of 14% demonstrates the company's ability to grow revenue over longer cycles despite intermediate downturns
- 5-year compounded profit growth of 36% shows strong long-term earnings compounding capability even though recent years have been weaker
- 5-year stock CAGR of 18% indicates sustained long-term wealth creation for shareholders
- The stock is trading near its 52-week high of ₹5,000, just 0.4% below the peak, reflecting strong positive price momentum
- P/E (TTM) of 81.74x is extremely elevated, implying the market is pricing in aggressive future earnings growth that may not materialize
- 3-year compounded profit growth of -24% indicates a severe and sustained earnings contraction over the medium term
- ROE of 7.25% is low for a company trading at 6.52x book value, suggesting the stock's valuation far exceeds returns generated on equity
- 3-year average ROE of 8% is modest and well below the 5-year average of 13%, pointing to a structural decline in return efficiency
- Dividend yield of just 0.06% with a payout of only 6.44% of profits over the last 3 years offers negligible income to shareholders
- There are indications the company might be capitalizing interest costs, which could flatter reported profitability and understate true operating expenses
- TTM profit growth of only 1% against 20% sales growth implies significant margin compression or rising costs eating into earnings
- The stock has rallied 70.7% from its 52-week low of ₹2,916.6, raising the risk of mean reversion if earnings fail to catch up with the price
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Gujarat Fluorochemicals delivered strong Q2FY27 results with 32% EBITDA growth and a 135% surge in fluorochemicals revenue on the back of R32 demand. The EV vertical is progressing with a new critical minerals subsidiary and ₹2,300 crore equity raise, though battery materials capex has been delayed by 1.5 quarters due to an Oman project shift. The core chemicals business is clearly firing, but investors should watch for further EV timeline slippages. The trend is improving on profitability, with execution risk concentrated in the EV buildout.
- EV battery capex delayed Nov 06
Battery materials capex pushed back by 1.5 quarters due to a shift of the project to Oman. This delays revenue realization from the planned ₹6,000 crore EV investment program.
- EBITDA up 32%, profit up 42% Nov 06
Consolidated EBITDA rose 32% YoY to ₹473 crore in Q2FY27, while net profit jumped 42% YoY to ₹240 crore.
- Fluorochemicals revenue surges 135% Nov 06
Fluorochemicals segment revenue surged 135% YoY to ₹607 crore, driven by strong R32 demand.
- ₹2,300 crore equity raised for EV Nov 06
Part of the ₹6,000 crore EV investment plan has been funded through ₹2,300 crore in equity, strengthening the balance sheet for long-term capex.
- New EV minerals subsidiary incorporated Nov 13
GFCL EV Critical Minerals Limited was incorporated on November 12, 2026 as a wholly owned subsidiary of GFCL EV Products Ltd.
- Investor conference participation Nov 09
Company representatives will attend two investor conferences in Mumbai on November 16–17, 2026, presenting Q2FY26 results.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 947 | 992 | 1,133 | 1,176 | 1,188 | 1,148 | 1,225 | 1,281 | 1,210 | 1,136 | 1,369 | 1,588 | 1,760 |
| Expenses | 783 | 786 | 895 | 914 | 893 | 854 | 919 | 937 | 846 | 861 | 1,062 | 1,162 | 1,287 |
| Operating Profit | 164 | 206 | 238 | 262 | 295 | 294 | 306 | 344 | 364 | 275 | 307 | 426 | 473 |
| OPM % | 17% | 21% | 21% | 22% | 25% | 26% | 25% | 27% | 30% | 24% | 22% | 27% | 27% |
| Other Income | 13 | 13 | 18 | 9 | 9 | 14 | 26 | 23 | 6 | −10 | 3 | 12 | 10 |
| Interest | 34 | 37 | 34 | 37 | 42 | 42 | 26 | 30 | 33 | 33 | 42 | 26 | 40 |
| Depreciation | 68 | 72 | 81 | 85 | 90 | 91 | 89 | 90 | 91 | 89 | 97 | 102 | 104 |
| PBT | 75 | 110 | 141 | 149 | 172 | 175 | 217 | 247 | 246 | 143 | 171 | 310 | 339 |
| Tax % | 29% | 27% | 28% | 28% | 30% | 28% | 12% | 26% | 27% | 29% | 42% | 29% | 29% |
| Net Profit | 53 | 80 | 101 | 108 | 121 | 126 | 191 | 182 | 179 | 102 | 100 | 219 | 240 |
| EPS (₹) | 4.82 | 7.28 | 9.19 | 9.83 | 11.02 | 11.47 | 17.39 | 16.57 | 16.29 | 9.29 | 9.38 | 20.12 | 22.12 |
| YoY Sales growth | −35 | −30 | −23 | −3 | 25 | 16 | 8 | 9 | 2 | −1 | 12 | 24 | 45 |
Profit & Loss
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,851 | 2,729 | 2,606 | 2,650 | 3,954 | 5,685 | 4,281 | 4,737 | 4,996 | 5,853 |
| Expenses | 3,105 | 1,941 | 2,167 | 2,052 | 2,785 | 3,719 | 3,366 | 3,638 | 3,795 | 4,372 |
| Operating Profit | 745 | 788 | 439 | 598 | 1,168 | 1,965 | 915 | 1,100 | 1,201 | 1,481 |
| OPM % | 19% | 29% | 17% | 23% | 30% | 35% | 21% | 23% | 24% | 25% |
| Other Income | 112 | 78 | 190 | 199 | 161 | 172 | 100 | 115 | 111 | 15 |
| Interest | 279 | 56 | 105 | 113 | 78 | 117 | 133 | 147 | 138 | 141 |
| Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 355 | 367 | 392 |
| PBT | 279 | 645 | 332 | 482 | 1,045 | 1,785 | 595 | 713 | 807 | 963 |
| Tax % | 14% | −93% | 43% | 146% | 26% | 26% | 27% | 23% | 29% | — |
| Net Profit | 240 | 1,246 | 189 | −222 | 776 | 1,323 | 435 | 546 | 574 | 661 |
| EPS (₹) | — | — | 17.87 | −19.91 | 71.66 | 120.97 | 39.59 | 49.71 | 52.56 | 60.91 |
| Div. Payout % | 15% | 0% | 0% | 0% | 6% | 3% | 8% | 6% | 6% | — |
| Sales growth | — | −29 | −4 | 2 | 49 | 44 | −25 | 11 | 5 | 20 |
Balance Sheet
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 4,756 | 3,499 | 3,705 | 3,482 | 4,244 | 5,510 | 5,925 | 7,242 | 7,855 | 8,381 |
| Borrowings | 2,000 | 968 | 1,718 | 1,591 | 1,556 | 1,515 | 2,096 | 2,080 | 2,721 | 2,331 |
| Other Liabilities | 2,986 | 441 | 634 | 885 | 1,067 | 1,335 | 1,201 | 1,270 | 1,273 | 2,118 |
| Total Liabilities | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 11,859 | 12,841 |
| Fixed Assets | 3,813 | 2,305 | 2,414 | 2,367 | 2,514 | 3,111 | 4,264 | 4,285 | 4,822 | 4,745 |
| CWIP | 724 | 229 | 318 | 400 | 680 | 1,158 | 1,128 | 1,568 | 1,900 | 2,457 |
| Investments | 524 | 342 | 259 | 88 | 20 | 1 | 1 | 289 | 277 | 50 |
| Other Assets | 4,691 | 2,042 | 3,076 | 3,114 | 3,665 | 4,101 | 3,840 | 4,460 | 4,860 | 5,589 |
| Total Assets | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 11,859 | 12,841 |
Cash Flow
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 952 | 782 | 546 | 616 | 741 | 739 | 626 | 545 | 961 |
| Investing | 589 | −428 | −1,152 | −373 | −584 | −476 | −966 | −1,121 | −1,168 |
| Financing | −1,668 | 110 | 622 | −248 | −144 | −264 | 348 | 599 | 367 |
| Net Cash Flow | −127 | 464 | 17 | −5 | 14 | −2 | 7 | 24 | 160 |
| Free Cash Flow | −64 | 276 | −650 | 343 | 92 | 12 | −330 | −335 | −292 |
| CFO/EBITDA | 157 | 101 | 136 | 80 | 83 | 62 | 90 | 67 | 101 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184 | 77 | 79 | 92 | 72 | 71 | 72 | 92 | 94 |
| Inventory Days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 487 | 453 |
| Days Payable | 471 | 127 | 176 | 202 | 170 | 174 | 144 | 162 | 129 |
| Cash Conversion Cycle | 449 | 301 | 293 | 294 | 216 | 272 | 363 | 418 | 417 |
| Working Capital Days | 67 | 22 | 0 | 6 | 33 | 62 | 60 | 97 | 92 |
| ROCE % | — | 11% | 9% | 11% | 20% | 30% | 10% | 10% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gujarat Fluorochemicals insights
63 extracted metrics across FY18–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · Jun 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- 26 Mar 2026
- 28 Jul 2025
- 26 Mar 2025
- 26 Dec 2024
- 1 Oct 2024
- General announcements 9 Nov 2026
Frequently Asked Questions about Gujarat Fluorochemicals
What does Gujarat Fluorochemicals Ltd do?
Where is Gujarat Fluorochemicals Ltd (FLUOROCHEM) listed?
Which sector does Gujarat Fluorochemicals Ltd belong to?
What is the market capitalisation of Gujarat Fluorochemicals Ltd?
What is the PE ratio of Gujarat Fluorochemicals Ltd?
What is the 52-week high and low of Gujarat Fluorochemicals Ltd?
Does Gujarat Fluorochemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Gujarat Fluorochemicals Ltd?
Company Information
Incorporated in 2018, Gujarat Fluorochemicals Limited, earlier known as Inox Fluorochemicals Limited, is a part of the INOX Group of Companies and has been demerged from GFL Ltd, into a separate legal entity. It is one of the leading producers of Fluoro-polymers, Fluoro-specialities, Chemicals and Refrigerants in India. It is one of the top five global players in the fluoropolymers market with exports to Europe, Americas, Japan and Asia.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FLUOROCHEM.md for Gujarat Fluorochemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.